Shanghai Bio-heart Biological Technology Co (HKSE:02185) ROCE %: -15.41% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02185 Shanghai Bio-heart Biological Technology Co Ltd HKSE:02185
28 GF Score
Price HK$2.31
! 3 Warning Signs
View Full Analysis

What is Shanghai Bio-heart Biological Technology Co ROCE %?

Shanghai Bio-heart Biological Technology Co HKSE:02185 -2.33% 28 ROCE % is -15.41% as of Dec. 2025. GuruFocus rates HKSE:02185 with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Bio-heart Biological Technology Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -15.41%.

Shanghai Bio-heart Biological Technology Co  (HKSE:02185) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Bio-heart Biological Technology Co ROCE % Related Terms

Shanghai Bio-heart Biological Technology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shanghai Bio-heart Biological Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bio-heart Biological Technology Co ROCE % Chart

Shanghai Bio-heart Biological Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -44.84 -21.54 -21.26 -12.18 -11.65

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.23 -7.17 -17.44 -6.21 -15.41
HKSE:02185
28GF Score
Shanghai Bio-heart Biological Technology Co Ltd HKSE:02185
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Bio-heart Biological Technology Co ROCE % Calculation

Shanghai Bio-heart Biological Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-96.399/( ( (783.432 - 20.979) + (919.659 - 27.652) )/ 2 )
=-96.399/( (762.453+892.007)/ 2 )
=-96.399/827.23
=-11.65 %

Shanghai Bio-heart Biological Technology Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-139.862/( ( (960.162 - 36.531) + (919.659 - 27.652) )/ 2 )
=-139.862/( ( 923.631 + 892.007 )/ 2 )
=-139.862/907.819
=-15.41 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -15.41% mean?
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a ROCE % of -15.41% as of Dec. 2025.
Is Shanghai Bio-heart Biological Technology Co's ROCE % too high?
Shanghai Bio-heart Biological Technology Co's current ROCE % is -15.41%. Overall, Shanghai Bio-heart Biological Technology Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bio-heart Biological Technology Co's ROCE % compare to VRTX and REGN?
Shanghai Bio-heart Biological Technology Co's ROCE % of -15.41% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Shanghai Bio-heart Biological Technology Co's current ROCE % is -15.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bio-heart Biological Technology Co stock overvalued right now?
Shanghai Bio-heart Biological Technology Co (HKSE:02185) has a current ROCE % of -15.41%. The current ROCE % is -15.41%. Shanghai Bio-heart Biological Technology Co's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shanghai Bio-heart Biological Technology Co (HKSE:02185), the current ROCE % is -15.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Bio-heart Biological Technology Co Business Description

Address No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.
28GF Score

Get the complete analysis for HKSE:02185

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.31
Price